Cargando…
A Robust Approach for Identification of Cancer Biomarkers and Candidate Drugs
Background and objectives: Identification of cancer biomarkers that are differentially expressed (DE) between two biological conditions is an important task in many microarray studies. There exist several methods in the literature in this regards and most of these methods designed especially for unp...
Autores principales: | Shahjaman, Md., Rahman, Md. Rezanur, Islam, S. M. Shahinul, Mollah, Md. Nurul Haque |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631768/ https://www.ncbi.nlm.nih.gov/pubmed/31212673 http://dx.doi.org/10.3390/medicina55060269 |
Ejemplares similares
-
Metabolomic Biomarker Identification in Presence of Outliers and Missing Values
por: Kumar, Nishith, et al.
Publicado: (2017) -
Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis
por: Rahman, Md. Rezanur, et al.
Publicado: (2019) -
Serum and Plasma Metabolomic Biomarkers for Lung Cancer
por: Kumar, Nishith, et al.
Publicado: (2017) -
Robust Feature Selection Approach for Patient Classification using Gene Expression Data
por: Shahjaman, Md., et al.
Publicado: (2017) -
Robust Significance Analysis of Microarrays by Minimum β-Divergence Method
por: Shahjaman, Md., et al.
Publicado: (2017)